Topics

Latest "Taymax Group Holdings, LP" News Stories - Page: 4

06:46 EST 12th November 2019 | BioPortfolio

Here are the most relevant search results for "Taymax Group Holdings, LP" found in our extensive news archives from over 250 global news sources.

More Information about Taymax Group Holdings, LP on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Taymax Group Holdings, LP for you to read. Along with our medical data and news we also list Taymax Group Holdings, LP Clinical Trials, which are updated daily. BioPortfolio also has a large database of Taymax Group Holdings, LP Companies for you to search.

Showing "Taymax Group Holdings" News Articles 76–100 of 8,200+

Friday 8th November 2019

How A Thriving, Armed White Supremacist Group Operates In Plain Sight

ProPublica spent several months examining the makeup and operations of Patriot Front, a group that was formed in the aftermath of the deadly “Unite the Right” rally in Charlottesville, Virginia, in 2017. In other public health news: childbirth, meth addiction, hygiene, walking, toxic chemicals and more.


Replimune Group (REPL) Presents At 34th Annual Meeting of SITC - Slideshow

Horizon Discovery divests animal models business to Envigo.

  Animal model operations to be transferred to Envigo ownership Divestment in line with Horizon’s corporate strategy to focus on its core markets  Envigo, a leading global research model supplier, enters the gene-edited research model field with the addition of Horizon’s business Horizon and Envigo to collaborate on providing CRISPR screening services Ca...


Game-changing diagnostic test for prion diseases

Researchers have developed an effective way of testing for prion diseases, a group of fatal neurodegenerative illnesses caused by abnormally folded proteins.

World Shortage of Helium

For once we can’t blame Brexit! There is a world shortage of Helium, the shortage of Helium is a natural phenomenon. Helium forms below the earth’s surface, formed from the slow radioactive alpha decay that occurs in rocks. Helium is a colourless, odourless, tasteless, non-toxic, inert, monatomic gas and is the first of the noble gas group on the periodic table of the elements. After H...

New HIV strain discovered, the first in almost 2 decades

Abbott researchers have identified a new and rare human immunodeficiency virus strain called HIV-1 group M subtype L, accordi -More- 

Newpharma collaborates with Ingenico for e-payments

Belgian online pharmacy firm Newpharma has partnered with UK-based payments company Ingenico Group to enable secure payments for pharmaceutical customers....Read More... The post Newpharma collaborates with Ingenico for e-payments appeared first on Pharmaceutical Technology.

LHC Group, Inc. 2019 Q3 - Results - Earnings Call Presentation

Horizon Discovery Divests Animal Models Business to Envigo

Animal model operations to be transferred to Envigo ownership Divestment in line with Horizon’s corporate strategy to focus on its core markets Envigo, a leading global research model supplier, enters the gene-edited research model field with the addition of Horizon’s business Horizon and Envigo to collaborate on providing CRISPR screening services Horizon Discovery Group plc (LSE: H...

Adama in JV with China’s Huifeng Prior to Takeover

Following the signing of a Memorandum of Understanding in January, Adama and China’s Jiangsu Huifeng Bio Agriculture have now entered into a joint venture in advance of a larger transaction in which the Israeli agrochemicals group envisages acquiring Huifeng’s overall business.

RHÖN-KLINIKUM AG Confirms Guidance for 2019 Following Increase in Revenues in the Third Quarter and in the First Nine Months

DGAP-News: RHÖN-KLINIKUM AG / Key word(s): Quarter Results/Quarter Results 08.11.2019 / 07:04 The issuer is solely responsible for the content of this announcement. Corporate News Bad Neustadt / Saale | 8th November 2019 RHÖN-KLINIKUM AG Confirms Guidance for 2019 Following Increase in Revenues in the Third Quarter and in the First Nine Months   Revenues i...

Thursday 7th November 2019

Exelixis’ Collaborator Daiichi Sankyo Announces Positive Results From Phase 3 Pivotal Trial of Esaxerenone in Patients With Diabetic Nephropathy

-- Results being presented today in a late-breaking presentation (abstract TH-PO1201) at Kidney Week 2019, the annual meeting of the American Society of Nephrology in Washington, D.C. Exelixis, Inc. (Nasdaq: EXEL) announced today that its partner Daiichi Sankyo Company, Lim

Fossil suggests apes, old world monkeys moved in opposite directions from shared ancestor

(American Museum of Natural History) In terms of their body plan, Old World monkeys -- a group that includes primates like baboons and macaques -- are generally considered more similar to ancestral species than apes are. But a new study suggests that as far as locomotion goes, apes and Old World monkeys each evolved a way of moving that was different from the ancestral species as they adapted to d...

Scientists' panel urges vigorous prevention of sexual harassment and bias in labs

(University of Massachusetts Amherst) A diverse group of scientists including Nilanjana Dasgupta, professor of social psychology at UMass Amherst and the campus's director of faculty equity and inclusion, report their findings recently and recommendations on how institutions and funding agencies can address and prevent sexual harassment and gender bias in the STEM workforce. Details of their sugge...

Bio-Path Holdings to Announce Third Quarter 2019 Financial Results on November 15, 2019

HOUSTON, Nov. 08, 2019 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc., (NASDAQ: BPTH), a biotechnology company leveraging its proprietary DNAbilize® antisense RNAi nanoparticle technology to develop a portfolio of targeted nucleic acid cancer drugs, today announced that it will host a live conference call and audio webcast on Friday, November 15, 2019 at 8:30 a.m. ET to report financial res...

NTG Nordic Transport Group implements share capital reduction of nominally DKK 7

Company announcement no. 40 - 19 8 November 2019 NTG Nordic Transport Group implements share capital reduction of nominally DKK 7 At the extraordinary general meeting of the NTG Nordic Transport Group A/S (the "Company") held on 7 October 2019 a proposal to reduce the Company's share capital from DKK 448,547,527 by DKK 7.00 to DKK 448,547,520 by transfer to a special reserve was adopted...

Conservation scientists call for reverse to biodiversity loss

(University of Queensland) A group of international conservationists is urging governments across the globe to adopt a new approach to address the impact of economic development on the natural world.Renowned researchers, including University of Queensland scientists, aim to draw attention to what they call "net positive outcomes for nature".

Researchers report new insights into Parkinson's disease-related mortality

(IOS Press) By following a group of newly diagnosed patients with Parkinson's disease (PD) for a decade or more, researchers have been able to identify several factors never before reported that appear to be associated with higher mortality rates in PD patients compared to the general population. As reported in the Journal of Parkinson's Disease, these factors are early onset of PD, early impairme...

Kadmon Holdings, Inc.: Kadmon Provides Business Update and Reports Third Quarter 2019 Financial Results

NEW YORK, NY / ACCESSWIRE / November 7, 2019 / Kadmon Holdings, Inc. (NYSE:KDMN) today provided a business update and reported financial and operational results for the third quarter of 2019. "Foll...

PolarityTE Adopts Short-Term Shareholder Rights Plan

PolarityTE, Inc. (Nasdaq: PTE), a biotechnology company developing and commercializing regenerative tissue products and biomaterials, today announced that its Board of Directors approved a short-term shareholder rights agreement (“the Rights Agreement”) following an evaluation by the Shareholder Rights Committee established by the Board in August 2019. The Rights Agreement is intended to en...

TOT BIOPHARM (1875.HK) Proceeded with IPO raising over HK$500 million

Dedicated to Developing and Commercializing Innovative Oncology Drugs and Therapies Propelling Future Growth HONG KONG, Nov. 7, 2019 /PRNewswire/ -- A clinical-stage biopharmaceutical company with full industry value chain capabilities, TOT BIOPHARM International Company Limited ("TOT BIOPHARM" or the "Company", together with its subs...

Check out #CareTalk @HLTH2019

CareCentrix CEO, John Driscoll and I talk #CareTalk on the road to the HLTH conference in Las Vegas, where we interviewed some big names include Obamacare architect Zeke Emmanuel, Former CMS Administrator Andy Slavitt, Former Congressman Patrick Kennedy, Walmart Health exec Marcus Osborne, and Boston Children’s Chief Innovation Officer John Brownstein. You can check out Read More The post Ch...

The Battle for the Future of Food in Africa

by Million Belay and Timothy Wise Last month in Ghana, Agnes Kalibata, President of the Alliance for a Green Revolution in Africa, congratulated an illustrious group of corporate and government leaders for “leapfrogging into the future” ...

All-in-one Digital Health & Fitness Platform Openfit Launches With Live Trainer-led Workouts and Personalized Nutrition

Offering Unlimited Classes and Full Nutrition Planning for less than $15 Per Month, Openfit Streamlines Healthy Living and Fitness for All Openfit, the all-in-one digital platform for fitness, nutrition and wellness, launches today with a certified trainer-led live group fitness experience that is integrated with personalized, easy-to-follow nutrition programming and tracking, making it possible...

New open source Design Thinking for Health curriculum launched for nurses

Nurses make up the largest and most trusted group of health care professionals, work on the front lines of the health care system, and are frequently called on to devise on-the-spot solutions to urgent health care problems, yet most nurses receive little or no training in how to effectively address these design challenges.


Quick Search

News Quicklinks